Veeda Clinical Research has announced the appointment of Dr Mahesh Bhalgat as the Group CEO. Dr Bhalgat is an accomplished leader and professional with more than three decades of a successful career in developing business strategies, driving growth, spearheading multiple initiatives across several verticals, and managing operations in diverse businesses including, Biopharmaceuticals, Vaccines, Contract Research Organization (CRO), Contract Development and Manufacturing Organization (CDMO),  Agricultural Biotechnology, and Research reagents and services space.

At Veeda, Dr Bhalgat will provide strategic leadership and drive the integration of different business segments to build a multinational integrated technology-enabled, clinical research organization by overseeing a diverse portfolio of research services of Veeda group companies, which includes Preclinical Research business (Bioneeds India), and Clinical Research entity (Veeda Clinical Research).

Dr Bhalgat has vast experience of being in a senior leadership roles. Prior to joining Veeda, Mahesh was the Chief Operating Officer (COO) for Syngene International (Biocon Group Company). Prior to that, he was the COO and Executive Director for Sanofi in Hyderabad, where he was responsible for initiating the first-ever Indian manufacturing operation for injectable polio vaccine. Dr Bhalgat started his India career with Biological E, which he joined after 20 years in North America pursuing his study and working with multi-national drug development companies, which include Amgen and Monsanto and Thermofisher.